Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Operating Expenses (2020 - 2025)

Agilon Health (AGL) has disclosed Operating Expenses for 6 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 8.14% year-over-year to $1.8 billion, compared with a TTM value of $6.4 billion through Dec 2025, up 0.68%, and an annual FY2025 reading of $6.4 billion, up 0.68% over the prior year.
  • Operating Expenses was $1.8 billion for Q4 2025 at Agilon Health, up from $1.6 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.8 billion in Q4 2025 and bottomed at $177.0 million in Q4 2021.
  • Average Operating Expenses over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
  • The sharpest move saw Operating Expenses crashed 50.94% in 2021, then soared 187.93% in 2023.
  • Year by year, Operating Expenses stood at $177.0 million in 2021, then surged by 139.48% to $423.8 million in 2022, then skyrocketed by 187.93% to $1.2 billion in 2023, then skyrocketed by 33.61% to $1.6 billion in 2024, then rose by 8.14% to $1.8 billion in 2025.
  • Business Quant data shows Operating Expenses for AGL at $1.8 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.5 billion in Q2 2025.